UTMD's Q2 Earnings Slip Y/Y Due to Falling OEM Sales, Stock Down 3%
Utah Medical's Q2 earnings decrease year over year on lower OEM sales and weak international demand, though cost controls helped cushion margins.
Zacks·1mo ago
More News
Top Analyst Reports for JPMorgan, Novartis & AT&T
JPM's strong NII outlook, NVS's blockbuster pipeline, and T's wireless momentum anchor today's top analyst picks.
Zacks·3mo ago
The Zacks Analyst Blog Highlights Apple, Mastercard, Amgen, Utah Medical Products and Bridger Aerospace
Apple, Mastercard, Amgen, Utah Medical Products and Bridger Aerospace are part of the Zacks top Analyst Blog...
Yahoo! Finance: Company News·1y ago
Top Stock Reports for Apple, Mastercard & Amgen
Today's Research Daily features new research reports on 16 major stocks, including Apple (AAPL), Mastercard (MA) and Amgen (AMGN), as well as two micro-cap stocks Utah Medical Products, Inc. (UTMD...
Yahoo! Finance: Company News·1y ago
Utah Medical Products: An Attractive, But Speculative, Prospect
Utah Medical Products: An Attractive, But Speculative, Prospect...
SeekingAlpha·1y ago
Utah Medical Products (UTMD, $68.64) Stochastic Oscillator left the oversold zone on March 18, 2024
This is a signal that UTMD's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options...
Tickeron - Stocks·1y ago
Utah Medical Products About To Put More Money In Your Pocket (UTMD)
On 3/14/24, Utah Medical Products, Inc. (UTMD) will trade ex-dividend, for its quarterly dividend of 0.30, payable on 4/3/24...
Dividend Channel·1y ago
Utah Medical Products (NASDAQ:UTMD) Lowered to "Buy" at StockNews.com
StockNews.com lowered shares of Utah Medical Products (NASDAQ:UTMD Free Report) from a strong-buy rating to a buy rating in a research report sent to investors on Thursday.
Separately...
Zolmax·2y ago
Natixis Advisors L.P. Invests $1.10 Million in Utah Medical Products, Inc. (NASDAQ:UTMD)
Natixis Advisors L.P. purchased a new position in shares of Utah Medical Products, Inc. (NASDAQ:UTMD Free Report) in the 3rd quarter, according to the company in its most recent disclosure...
Zolmax·2y ago
Utah Medical Products (UTMD, $69.8) Stochastic Oscillator left the oversold zone on March 07, 2024
This is a signal that UTMD's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options...